Profile | GDS4284 / 238476_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3082.87 | 89 |
GSM687648 | Patient 402 control | 2897.15 | 88 |
GSM687653 | Patient 403 control | 2988.99 | 89 |
GSM687658 | Patient 404 control | 2580.22 | 87 |
GSM687663 | Patient 411 control | 2559.56 | 87 |
GSM687668 | Patient 422 control | 3023.61 | 89 |
GSM687673 | Patient 424 control | 2551.19 | 87 |
GSM687678 | Patient 425 control | 2576.54 | 87 |
GSM687683 | Patient 427 control | 3426.18 | 90 |
GSM687688 | Patient 428 control | 2698.83 | 88 |
GSM687695 | Patient 441 control | 4756.78 | 93 |
GSM687699 | Patient 443 control | 1855.09 | 83 |
GSM687704 | Patient 444 control | 2382.8 | 86 |
GSM687707 | Patient 448 control | 2339.85 | 86 |
GSM687712 | Patient 449 control | 3790.81 | 91 |
GSM687719 | Patient 450 control | 2120.36 | 85 |
GSM687724 | Patient 451 control | 2779.59 | 88 |
GSM687728 | Patient 452 control | 3128.86 | 89 |
GSM687646 | Patient 401 treated 24h | 3765.14 | 91 |
GSM687649 | Patient 402 treated 24h | 3044.72 | 89 |
GSM687665 | Patient 411 treated 24h | 2651.1 | 87 |
GSM687651 | Patient 402 treated 4 weeks | 2472.33 | 87 |
GSM687667 | Patient 411 treated 4 weeks | 2687.44 | 87 |
GSM687670 | Patient 422 treated 24h | 2771.25 | 88 |
GSM687671 | Patient 422 treated 4 weeks | 2925.87 | 88 |
GSM687654 | Patient 403 treated 24h | 2720.45 | 88 |
GSM687675 | Patient 424 treated 24h | 2597.39 | 87 |
GSM687685 | Patient 427 treated 24h | 2877.6 | 88 |
GSM687656 | Patient 403 treated 4 weeks | 2901 | 88 |
GSM687677 | Patient 424 treated 4 weeks | 1983 | 84 |
GSM687687 | Patient 427 treated 4 weeks | 3164.81 | 89 |
GSM687692 | Patient 428 treated 4h | 2595.89 | 87 |
GSM687716 | Patient 449 treated 4h | 3519.12 | 90 |
GSM687722 | Patient 450 treated 4h | 2836.05 | 88 |
GSM687680 | Patient 425 treated 24h | 3762.72 | 91 |
GSM687690 | Patient 428 treated 24h | 2410.21 | 86 |
GSM687700 | Patient 443 treated 24h | 3070.66 | 89 |
GSM687705 | Patient 444 treated 24h | 1845.88 | 83 |
GSM687714 | Patient 449 treated 24h | 3516.87 | 90 |
GSM687721 | Patient 450 treated 24h | 3506 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 3044.92 | 89 |
GSM687694 | Patient 428 treated 4 weeks | 2502.92 | 86 |
GSM687702 | Patient 443 treated 4 weeks | 2477.63 | 87 |
GSM687718 | Patient 449 treated 4 weeks | 3004.19 | 89 |
GSM687723 | Patient 450 treated 4 weeks | 1911.49 | 83 |
GSM687661 | Patient 404 treated 4h | 2139.66 | 85 |
GSM687710 | Patient 448 treated 4h | 2295.24 | 86 |
GSM687726 | Patient 451 treated 4h | 2869.32 | 88 |
GSM687730 | Patient 452 treated 4h | 2188.14 | 87 |
GSM687660 | Patient 404 treated 24h | 5260.26 | 94 |
GSM687697 | Patient 441 treated 24h | 4318.99 | 92 |
GSM687709 | Patient 448 treated 24h | 1943.78 | 84 |
GSM687725 | Patient 451 treated 24h | 2551.37 | 87 |
GSM687729 | Patient 452 treated 24h | 3452.92 | 91 |
GSM687727 | Patient 451 treated 4 weeks | 2660.8 | 87 |
GSM687731 | Patient 452 treated 4 weeks | 3485.2 | 90 |